374 related articles for article (PubMed ID: 29636020)
1. Sarcomatoid renal cell carcinoma: a case report and literature review.
Liang X; Liu Y; Ran P; Tang M; Xu C; Zhu Y
BMC Nephrol; 2018 Apr; 19(1):84. PubMed ID: 29636020
[TBL] [Abstract][Full Text] [Related]
2. FDG PET/CT and CT Findings of Renal Cell Carcinoma With Sarcomatoid Differentiation.
Zhu H; Zhao S; Zuo C; Ren F
AJR Am J Roentgenol; 2020 Sep; 215(3):645-651. PubMed ID: 32755159
[No Abstract] [Full Text] [Related]
3. Widespread metastases from sarcomatoid renal cell carcinoma detected by (18)F-FDG positron emission tomography/computed tomography.
Hyodo T; Sugawara Y; Tsuda T; Yanagihara Y; Aoki K; Tanji N; Hirata M; Murakami M; Miyagawa M; Yokoyama M; Mochizuki T
Jpn J Radiol; 2009 Feb; 27(2):111-4. PubMed ID: 19373542
[TBL] [Abstract][Full Text] [Related]
4. Sarcomatoid renal cell carcinoma: rapid dissemination detected on FDG PET-CT.
Thambugala GM; Mohamed A; O' Neill GF; Fulham MJ
Australas Radiol; 2006 Dec; 50(6):604-6. PubMed ID: 17107535
[TBL] [Abstract][Full Text] [Related]
5. FDG PET/CT of Chromophobe Renal Cell Carcinoma With Sarcomatoid Differentiation.
Lee CH; Kesari V; Legesse T; Chen W
Clin Nucl Med; 2018 May; 43(5):367-369. PubMed ID: 29485439
[TBL] [Abstract][Full Text] [Related]
6. Enhanced MRI and 18F-FDG PET/CT Findings of Preoperative Primary Renal Collecting Duct Carcinoma.
Ge J; Zuo C; Guan Y; Liang Z
Clin Nucl Med; 2016 Dec; 41(12):998-999. PubMed ID: 27775947
[TBL] [Abstract][Full Text] [Related]
7. Role of Positron Emission Tomography Imaging in Metabolically Active Renal Cell Carcinoma.
Karivedu V; Jain AL; Eluvathingal TJ; Sidana A
Curr Urol Rep; 2019 Aug; 20(10):56. PubMed ID: 31468240
[TBL] [Abstract][Full Text] [Related]
8. Transitional cell carcinoma with extension of the renal vein and IVC tumor thrombus: report of three cases and literature review.
Li M; Shi A; Kong W; Zhang J; Chen Y; Huang J; Huang Y
World J Surg Oncol; 2016 Dec; 14(1):309. PubMed ID: 28031042
[TBL] [Abstract][Full Text] [Related]
9. Treatments, Outcomes, and Validity of Prognostic Scores in Patients With Sarcomatoid Renal Cell Carcinoma: A 20-Year Single-Institution Experience.
Korenbaum C; Pierard L; Thiéry A; Story F; Lindner V; Lang H; Kurtz JE; Barthélémy P
Clin Genitourin Cancer; 2018 Jun; 16(3):e577-e586. PubMed ID: 29395949
[TBL] [Abstract][Full Text] [Related]
10. [Case of renal cell carcinoma with intertrabecular vertebral metastases detected f-18 fluorodeoxyglucose positron emission tomography and MRI].
Yoneyama S; Yumura Y; Koizumi M; Hanai T; Ishida H; Hattori Y; Teranishi J; Miyoshi Y; Kondo K; Noguchi K
Hinyokika Kiyo; 2014 Jan; 60(1):29-32. PubMed ID: 24594770
[TBL] [Abstract][Full Text] [Related]
11. Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma.
Park JW; Jo MK; Lee HM
BJU Int; 2009 Mar; 103(5):615-9. PubMed ID: 19007371
[TBL] [Abstract][Full Text] [Related]
12. Grade 4 unclassified renal cell carcinoma with sarcomatoid component expressing S-100 protein. A case report with peculiar diagnostic and therapeutic implications.
Miolo G; Ash A; Buonadonna A; Lo Re G; Torrisi E; Cervo S; Santeufemia DA; Tuzi A; Canzonieri V
Cancer Biol Ther; 2014; 15(11):1439-43. PubMed ID: 25482943
[TBL] [Abstract][Full Text] [Related]
13. Impact of histologic subtype and sarcomatoid transformation on metastasis in renal cell carcinoma: a single institute experience in 149 patients.
Tirumani SH; Souza D; Krajewski KM; Jagannathan JP; Ramaiya NH; Shinagare AB
Abdom Radiol (NY); 2016 Feb; 41(2):295-302. PubMed ID: 26867911
[TBL] [Abstract][Full Text] [Related]
14. A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses.
Ozülker T; Ozülker F; Ozbek E; Ozpaçaci T
Nucl Med Commun; 2011 Apr; 32(4):265-72. PubMed ID: 21301376
[TBL] [Abstract][Full Text] [Related]
15. Rapidly Progressing Renal Cell Cancer of the Left Native Kidney in a Renal Transplant Recipient With Unusual Sites of Metastasis Demonstrated in Serial 18F-FDG PET/CT.
Rangan B K K; Ora M; Suraj AS; Parashar A; Gambhir S
Clin Nucl Med; 2019 Oct; 44(10):e574-e576. PubMed ID: 31348078
[TBL] [Abstract][Full Text] [Related]
16. F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma.
Majhail NS; Urbain JL; Albani JM; Kanvinde MH; Rice TW; Novick AC; Mekhail TM; Olencki TE; Elson P; Bukowski RM
J Clin Oncol; 2003 Nov; 21(21):3995-4000. PubMed ID: 14581422
[TBL] [Abstract][Full Text] [Related]
17. Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma.
Ramdave S; Thomas GW; Berlangieri SU; Bolton DM; Davis I; Danguy HT; Macgregor D; Scott AM
J Urol; 2001 Sep; 166(3):825-30. PubMed ID: 11490227
[TBL] [Abstract][Full Text] [Related]
18. [Renal cell carcinoma with rhabdoid features and sarcomatoid change: a case report].
Fukata S; Karashima T; Toi M; Kuroda N; Shuin T
Hinyokika Kiyo; 2010 Apr; 56(4):221-3. PubMed ID: 20448446
[TBL] [Abstract][Full Text] [Related]
19. Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT.
Alongi P; Picchio M; Zattoni F; Spallino M; Gianolli L; Saladini G; Evangelista L
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):464-73. PubMed ID: 26268680
[TBL] [Abstract][Full Text] [Related]
20. The Isolated Humeral Metastasis as the Initial Presentation of Renal Cell Carcinoma Revealed by 18 F-FDG PET/CT.
Hou G; Zhang W; Zheng R
Clin Nucl Med; 2023 Jun; 48(6):538-539. PubMed ID: 36976679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
